Myocardial protective effect of urethane on isolated rat hearts in prolonged hypothermic preservation. 2009

Zhenxiao Jin, and Tiejun Wu, and Shenghui Bi, and Heping Zhou, and Qin Cui, and Jingjun Zhou, and Xiaojun Kang, and Dinghua Yi, and Weiyong Liu
Department of Cardiovascular Surgery, Xijing Hospital, Xi'an, China.

BACKGROUND One of the most important factors restricting heart transplantation is the limited myocardial ischemia time. This study investigated the effects of urethane on the hypothermic preservation of donor rat hearts. METHODS Hearts isolated from rats were divided into 2 groups (n = 8), a control group with histidine-tryptophan-ketoglutarate (HTK) solution alone and an experimental group with HTK solution plus 30 mM urethane. Hearts were mounted on a Langendorff apparatus to estimate the baseline cardiac function; the hearts were then arrested and stored in one of the 2 solutions for 6 hours and 18 hours at 4 degrees C. After preservation, the hearts were reperfused, and cardiac function was evaluated. Lactate dehydrogenase (LDH) release, adenosine triphosphate (ATP) content, cardiomyocyte apoptosis, and myocardial ultrastructure were examined. RESULTS Compared with the control group, the experimental group showed a significantly higher recovery of cardiac function for both 6 hours and 18 hours of preservation and demonstrated a lower rate of cardiomyocyte apoptosis (8.5% + or - 1.2% versus 12.2% + or - 1.8% for 6 hours; 14.1% + or - 2.1% versus 31.4% + or - 2.7% for 18 hours). ATP content was significantly higher in the experimental group than in the control group after 18 hours of preservation (229.4 + or - 29.7 microg/g versus 153.2 + or - 21.1 microg/g). The experimental group also showed lower levels of LDH release after 18 hours of preservation. Electron microscopy studies demonstrated better cardiomyocyte structure in the experimental group for both 6 hours and 18 hours of preservation. CONCLUSIONS Use of urethane improved cardiac functional recovery and led to significant protective effects on rat hearts placed in a hypothermic preservation solution for a prolonged period.

UI MeSH Term Description Entries
D007036 Hypothermia, Induced Abnormally low BODY TEMPERATURE that is intentionally induced in warm-blooded animals by artificial means. In humans, mild or moderate hypothermia has been used to reduce tissue damages, particularly after cardiac or spinal cord injuries and during subsequent surgeries. Induced Hypothermia,Mild Hypothermia, Induced,Moderate Hypothermia, Induced,Targeted Temperature Management,Therapeutic Hypothermia,Hypothermia, Therapeutic,Induced Mild Hypothermia,Induced Mild Hypothermias,Induced Moderate Hypothermia,Induced Moderate Hypothermias,Mild Hypothermias, Induced,Moderate Hypothermias, Induced,Targeted Temperature Managements
D008297 Male Males
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009926 Organ Preservation The process by which organs are kept viable outside of the organism from which they were removed (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). Organ Preservations,Preservation, Organ,Preservations, Organ
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014520 Urethane Antineoplastic agent that is also used as a veterinary anesthetic. It has also been used as an intermediate in organic synthesis. Urethane is suspected to be a carcinogen. Ethyl Carbamate,Urethan,Carbamate, Ethyl
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Zhenxiao Jin, and Tiejun Wu, and Shenghui Bi, and Heping Zhou, and Qin Cui, and Jingjun Zhou, and Xiaojun Kang, and Dinghua Yi, and Weiyong Liu
March 2012, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology,
Zhenxiao Jin, and Tiejun Wu, and Shenghui Bi, and Heping Zhou, and Qin Cui, and Jingjun Zhou, and Xiaojun Kang, and Dinghua Yi, and Weiyong Liu
October 2018, Life sciences,
Zhenxiao Jin, and Tiejun Wu, and Shenghui Bi, and Heping Zhou, and Qin Cui, and Jingjun Zhou, and Xiaojun Kang, and Dinghua Yi, and Weiyong Liu
December 1995, Japanese circulation journal,
Zhenxiao Jin, and Tiejun Wu, and Shenghui Bi, and Heping Zhou, and Qin Cui, and Jingjun Zhou, and Xiaojun Kang, and Dinghua Yi, and Weiyong Liu
January 1999, Transplantation proceedings,
Zhenxiao Jin, and Tiejun Wu, and Shenghui Bi, and Heping Zhou, and Qin Cui, and Jingjun Zhou, and Xiaojun Kang, and Dinghua Yi, and Weiyong Liu
October 1995, Journal of molecular and cellular cardiology,
Zhenxiao Jin, and Tiejun Wu, and Shenghui Bi, and Heping Zhou, and Qin Cui, and Jingjun Zhou, and Xiaojun Kang, and Dinghua Yi, and Weiyong Liu
November 2007, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences,
Zhenxiao Jin, and Tiejun Wu, and Shenghui Bi, and Heping Zhou, and Qin Cui, and Jingjun Zhou, and Xiaojun Kang, and Dinghua Yi, and Weiyong Liu
February 2012, Molecular medicine reports,
Zhenxiao Jin, and Tiejun Wu, and Shenghui Bi, and Heping Zhou, and Qin Cui, and Jingjun Zhou, and Xiaojun Kang, and Dinghua Yi, and Weiyong Liu
August 1995, The Journal of thoracic and cardiovascular surgery,
Zhenxiao Jin, and Tiejun Wu, and Shenghui Bi, and Heping Zhou, and Qin Cui, and Jingjun Zhou, and Xiaojun Kang, and Dinghua Yi, and Weiyong Liu
December 2020, Physiological research,
Zhenxiao Jin, and Tiejun Wu, and Shenghui Bi, and Heping Zhou, and Qin Cui, and Jingjun Zhou, and Xiaojun Kang, and Dinghua Yi, and Weiyong Liu
September 1989, [Hokkaido igaku zasshi] The Hokkaido journal of medical science,
Copied contents to your clipboard!